Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene
Cell Rep
.
2021 Feb 2;34(5):108730.
doi: 10.1016/j.celrep.2021.108730.
Authors
Johnathan Cooper-Knock
,
Sai Zhang
,
Kevin P Kenna
,
Tobias Moll
,
John P Franklin
,
Samantha Allen
,
Helia Ghahremani Nezhad
,
Alfredo Iacoangeli
,
Nancy Y Yacovzada
,
Chen Eitan
,
Eran Hornstein
,
Eran Elhaik
,
Petra Celadova
,
Daniel Bose
,
Sali Farhan
,
Simon Fishilevich
,
Doron Lancet
,
Karen E Morrison
,
Christopher E Shaw
,
Ammar Al-Chalabi
;
Project MinE ALS Sequencing Consortium
;
Jan H Veldink
,
Janine Kirby
,
Michael P Snyder
,
Pamela J Shaw
PMID:
33535055
PMCID:
PMC7856549
DOI:
10.1016/j.celrep.2021.108730
No abstract available
Publication types
Published Erratum
Grants and funding
ALCHALABI-DOBSON/APR14/829-791/MNDA_/Motor Neurone Disease Association/United Kingdom
G0600974/MRC_/Medical Research Council/United Kingdom
MR/L501529/1/MRC_/Medical Research Council/United Kingdom
MR/R024804/1/MRC_/Medical Research Council/United Kingdom